SciClone Pharmaceuticals Overview

Life ScienceCompany

Is SciClone Pharmaceuticals PE-backed?

Yes. SciClone Pharmaceuticals is owned by private equity investor Ascendent Capital Partners.

Where is SciClone Pharmaceuticals headquartered?

SciClone Pharmaceuticals is headquartered in Shanghai, China.

What is SciClone Pharmaceuticals’ revenue?

SciClone Pharmaceuticals disclosed revenue of 160M USD for 2016 and 157M USD for 2015.

How many employees does SciClone Pharmaceuticals have?

SciClone Pharmaceuticals has 570 employees.

What sector is SciClone Pharmaceuticals in?

SciClone Pharmaceuticals is a life science company.

When was SciClone Pharmaceuticals founded?

SciClone Pharmaceuticals was founded in 1989.

SciClone Pharmaceuticals

SciClone Pharmaceuticals Ltd.

22 F, Central Plaza, 381 Middle Huaihai Road,
Shanghai,
China,
www.sciclone.com

SciClone Pharmaceuticals is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. SciClone's proprietary lead product, ZADAXIN (thymalfasin), is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), and certain cancers, and as an immune system enhancer, according to the local regulatory approvals. SciClone Pharmaceuticals was founded in 1989 and is based in Shanghai, China.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for SciClone Pharmaceuticals

Life Science Companies , China Companies